Propella’s acute vision accurately locates new drug opportunities in the context of unmet patient needs. Our enlightened approach to the design and development of improved therapies brings welcome light and hope to patients and healthcare professionals.
bright light thinking
We accomplish our mission by thoroughly investigating and then re-designing or re-positioning active pharmaceutical ingredients (API) to yield improved therapies. Once an existing candidate is identified, we laser in on all aspects of its profile, including patents, unmet medical needs, and commercial opportunities. We then canvass patients, doctors, payers and other experts for insight and validation of a new development approach.
All of our drug product candidates have been patented by us and their active ingredients have been well studied previously, which provides for a risk-mitigated development path. Making new drugs that are more effective, tolerable, and convenient for patients is both smart science and great business. Brighter treatments lay ahead.